213 related articles for article (PubMed ID: 36010583)
1. Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors.
Gerber TS; Ridder DA; Schindeldecker M; Weinmann A; Duret D; Breuhahn K; Galle PR; Schirmacher P; Roth W; Lang H; Straub BK
Cells; 2022 Aug; 11(16):. PubMed ID: 36010583
[TBL] [Abstract][Full Text] [Related]
2. N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
Gerber TS; Ridder DA; Goeppert B; Brobeil A; Stenzel P; Zimmer S; Jäkel J; Metzig MO; Schwab R; Martin SZ; Kiss A; Bergmann F; Schirmacher P; Galle PR; Lang H; Roth W; Straub BK
Int J Cancer; 2024 May; 154(10):1857-1868. PubMed ID: 38212892
[TBL] [Abstract][Full Text] [Related]
3. Cell polarity development and protein trafficking in hepatocytes lacking E-cadherin/beta-catenin-based adherens junctions.
Théard D; Steiner M; Kalicharan D; Hoekstra D; van Ijzendoorn SC
Mol Biol Cell; 2007 Jun; 18(6):2313-21. PubMed ID: 17429067
[TBL] [Abstract][Full Text] [Related]
4. E-N-cadherin heterodimers define novel adherens junctions connecting endoderm-derived cells.
Straub BK; Rickelt S; Zimbelmann R; Grund C; Kuhn C; Iken M; Ott M; Schirmacher P; Franke WW
J Cell Biol; 2011 Nov; 195(5):873-87. PubMed ID: 22105347
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.
Lin CY; Lin CJ; Chen KH; Wu JC; Huang SH; Wang SM
FEBS Lett; 2006 May; 580(13):3042-50. PubMed ID: 16678166
[TBL] [Abstract][Full Text] [Related]
7. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver.
Kozyraki R; Scoazec JY; Flejou JF; D'Errico A; Bedossa P; Terris B; Fiorentino M; Bringuier AF; Grigioni WF; Feldmann G
Gastroenterology; 1996 Apr; 110(4):1137-49. PubMed ID: 8613003
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus core protein induces epithelial-mesenchymal transition in human hepatocytes by upregulating E12/E47 levels.
Tiwari I; Yoon MH; Park BJ; Jang KL
Cancer Lett; 2015 Jun; 362(1):131-8. PubMed ID: 25817725
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer.
Nita-Lazar M; Noonan V; Rebustini I; Walker J; Menko AS; Kukuruzinska MA
Cancer Res; 2009 Jul; 69(14):5673-80. PubMed ID: 19549906
[TBL] [Abstract][Full Text] [Related]
10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
11. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
12. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
Wu C; Cipollone J; Maines-Bandiera S; Tan C; Karsan A; Auersperg N; Roskelley CD
Differentiation; 2008 Feb; 76(2):193-205. PubMed ID: 17608733
[TBL] [Abstract][Full Text] [Related]
13. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
14. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence.
Zulehner G; Mikula M; Schneller D; van Zijl F; Huber H; Sieghart W; Grasl-Kraupp B; Waldhör T; Peck-Radosavljevic M; Beug H; Mikulits W
Am J Pathol; 2010 Jan; 176(1):472-81. PubMed ID: 20008139
[TBL] [Abstract][Full Text] [Related]
15. The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.
Yao D; Peng S; Dai C
BMC Cancer; 2013 Sep; 13():432. PubMed ID: 24059685
[TBL] [Abstract][Full Text] [Related]
16. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
[TBL] [Abstract][Full Text] [Related]
17. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
Han LL; Jia L; Wu F; Huang C
Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
[TBL] [Abstract][Full Text] [Related]
19. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition.
Feng B; Zhu Y; Sun C; Su Z; Tang L; Li C; Zheng G
Int J Biol Macromol; 2019 Sep; 137():32-44. PubMed ID: 31252022
[TBL] [Abstract][Full Text] [Related]
20. Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo.
Li W; Pei S; Zhang X; Qi D; Zhang W; Dou Y; Yang R; Yao X; Zhang Z; Xie S; Fang D; Sun H
Eur J Pharmacol; 2022 May; 922():174886. PubMed ID: 35292248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
